The Taiwan Food and Drug Administration (TFDA) announced Wednesday that two measures have been implemented to increase intravenous (IV) fluid supplies after a halt in production by Taiwan's major saline supplier sparked concerns about a shortage of the medical resource crucial for surgery.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares close up 0.97%
01/22/2025 01:58 PM - Society
Cold weather predicted for Lunar New Year
01/22/2025 01:46 PM - Politics
Taiwan urged to boost defense spending during Trump's second term
01/22/2025 12:12 PM - Society
Taiwan headline news
01/22/2025 10:39 AM - Business
Taiwan shares open higher
01/22/2025 10:01 AM